Table 2.
Humanitas cohort: patient characteristics
| Total no. | % | |
| Total evaluated | 182 | 100 |
| Gender | ||
| Male | 147 | 80.7 |
| Female | 35 | 19.3 |
| Histology | ||
| Adenocarcinoma ± BAC | 97 | 53.2 |
| Squamous cell carcinoma | 46 | 25.3 |
| Other | 39 | 21.5 |
| Smoking history | ||
| Never | 17 | 9.3 |
| Former | 98 | 53.8 |
| Current | 60 | 33.0 |
| Unknown | 7 | 3.9 |
| Pathological stage | ||
| III | 155 | 85.1 |
| IV | 27 | 14.9 |
| EGFR status: total evaluable | 156 | |
| FISH positive | 76 | 48.7 |
| FISH negative | 80 | 51.3 |
The table reports the clinical characteristics of 182 NSCLC patients who underwent radical surgery. Patients with metastatic disease received surgery following or at the same time of single brain or lung lesion removal.
EGFR, epidermal growth factor receptor.